CAVA Group hosts Q4 2025 earnings conference call

CAVA Group, Inc. conducted its fourth quarter and full year 2025 earnings conference call on February 24, 2026. The call featured company executives providing details on financial results and business progress. Investors can access the related earnings release on the company's investor website.

On February 24, 2026, at 5:00 PM EST, CAVA Group, Inc. (NYSE: CAVA) held its Q4 and full year 2025 earnings conference call. The session was recorded and moderated by an operator who welcomed participants and outlined instructions for the discussion.

Matt Milanovich, Senior Vice President of Finance, opened the call with greetings and directed attendees to the earnings release and Form 8-K filed with the SEC, available at investor.cava.com. He stated, "The purpose of this conference call is to give investors further details regarding the company's financial results as well as a general update on the company's progress."

Key company participants included Brett Schulman, Co-Founder, CEO, President, and Director, and Tricia Tolivar, Chief Financial Officer. Analysts from firms such as JPMorgan Chase & Co., William Blair & Company, Truist Securities, BofA Securities, and others joined to pose questions.

The call provided an overview of CAVA's performance for the period ending in 2025, though specific financial figures were detailed in the accompanying release rather than the introductory remarks provided in the transcript.

Связанные статьи

CCC Intelligent Solutions Holdings Inc. conducted its fourth quarter and full year 2025 earnings call on February 24, 2026. The session featured company executives discussing financial results announced earlier that day. Analysts from major financial firms participated in the conference.

Сообщено ИИ

Clover Health Investments, Corp. held its fourth quarter and full year 2025 earnings call on February 26, 2026. The conference featured company executives discussing results, with materials available on the investor website. Forward-looking statements were noted as subject to risks detailed in SEC filings.

Senseonics Holdings, Inc. conducted its fourth quarter and full year 2025 earnings call on March 2, 2026. The conference featured company executives and analysts discussing financial results. Forward-looking statements were highlighted with standard risk disclosures.

Сообщено ИИ

Pacira BioSciences, Inc. conducted its fourth quarter and full year 2025 earnings conference call on February 26, 2026. The call featured company executives discussing financial results. Participants included analysts from major financial firms.

 

 

 

Этот сайт использует куки

Мы используем куки для анализа, чтобы улучшить наш сайт. Прочитайте нашу политику конфиденциальности для дополнительной информации.
Отклонить